Salman Hoda

Salman Hoda has over 10 years of experience in the pharmaceutical industry, with a focus on business development and portfolio management. Salman is currently the SVP of Portfolio & Business Development at Agentix, a leading provider of cannabinoid-based medicines. Prior to joining Agentix, Salman was the Director of the Pharmaceutical Division at Green Sky Labs Inc., where they led the development of cannabinoid-based medicines. Before that, they were the Manager of Business Development and Portfolio Management at Apobiologix, where they were responsible for making recommendations to senior management on the existing and new product portfolio to extract maximum value for Apobiologix and ApoPharma. Salman has also attended several industry conferences to further establish a network within the industry, and maintain a current level of knowledge of target therapeutic areas.

Salman Hoda received their BSc from the University of Waterloo in Science before going on to get their MBA from the University of Toronto's Rotman School of Management in Marketing and Business Development.

They are on a team with David Fiene - Controller, Martin Schroeder - Chief Scientific Officer. Their manager is Rudy Mazzocchi, CEO, President & Chairman.